Takeuchi, Masayoshi
Kanazawa Medical University
14 papers on CoChatORCID 0000-0002-1057-3764
Most cited papers
- Verified
Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury
YONEKURA, H., YAMAMOTO, Y., SAKURAI, S., PETROVA, R. G., ABEDIN, M. J., LI, H., YASUI, K., TAKEUCHI, M., MAKITA, Z., TAKASAWA, S., et al. (2003) · Biochemical Journal
Advanced Glycation End Products researchRetinal Diseases and Treatments
Cited by 716
- Verified
Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice
Yamamoto, Y., Kato, I., Doi, T., Yonekura, H., Ohashi, S., Takeuchi, M., Watanabe, T., Yamagishi, S.-I., Sakurai, S., Takasawa, S., et al. (2001) · Journal of Clinical Investigation
Advanced Glycation End Products researchChronic Kidney Disease and Diabetes
Cited by 475
- Verified
Glucagon-Like Peptide-1 Receptor Agonist Inhibits Asymmetric Dimethylarginine Generation in the Kidney of Streptozotocin-Induced Diabetic Rats by Blocking Advanced Glycation End Product–Induced Protein Arginine Methyltranferase-1 Expression
Ojima, A., Ishibashi, Y., Matsui, T., Maeda, S., Nishino, Y., Takeuchi, M., Fukami, K., & Yamagishi, S.-I. (2013) · The American Journal of Pathology
Advanced Glycation End Products researchChronic Kidney Disease and Diabetes
Cited by 156
- Verified
Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects
Yamagishi, S.-I., Adachi, H., Nakamura, K., Matsui, T., Jinnouchi, Y., Takenaka, K., Takeuchi, M., Enomoto, M., Furuki, K., Hino, A., et al. (2006) · Metabolism
Advanced Glycation End Products researchChronic Kidney Disease and Diabetes
Cited by 148
- Verified
TAGE (toxic AGEs) hypothesis in various chronic diseases
Takeuchi, M., & Yamagishi, S. (2004) · Medical Hypotheses
Advanced Glycation End Products researchPotato Plant Research
Cited by 116
- Verified
Serum Levels of Advanced Glycation End Products (AGEs) are Independent Correlates of Insulin Resistance in Nondiabetic Subjects
Tahara, N., Yamagishi, S., Matsui, T., Takeuchi, M., Nitta, Y., Kodama, N., Mizoguchi, M., & Imaizumi, T. (2012) · Cardiovascular Therapeutics
Advanced Glycation End Products researchAdipokines, Inflammation, and Metabolic Diseases
Cited by 116
- Verified
Linagliptin Blocks Renal Damage in Type 1 Diabetic Rats by Suppressing Advanced Glycation End Products-Receptor Axis
Nakashima, S., Matsui, T., Takeuchi, M., & Yamagishi, S.-I. (2014) · Hormone and Metabolic Research
Advanced Glycation End Products researchChronic Kidney Disease and Diabetes
Cited by 90
- Verified
Oral L-Carnitine Supplementation Increases Trimethylamine-N-oxide but Reduces Markers of Vascular Injury in Hemodialysis Patients
Fukami, K., Yamagishi, S.-I., Sakai, K., Kaida, Y., Yokoro, M., Ueda, S., Wada, Y., Takeuchi, M., Shimizu, M., Yamazaki, H., et al. (2015) · Journal of Cardiovascular Pharmacology
Dialysis and Renal Disease ManagementMetabolism and Genetic Disorders
Cited by 84
- Verified
Positive association of serum levels of advanced glycation end products and high mobility group box–1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients
Nakamura, T., Sato, E., Fujiwara, N., Kawagoe, Y., Ueda, Y., Suzuki, T., Yamada, S., Takeuchi, M., Fukami, K., Ueda, S., et al. (2009) · Metabolism
Advanced Glycation End Products researchChronic Kidney Disease and Diabetes
Cited by 53
- Verified
Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock
Nakamura, T., Sato, E., Fujiwara, N., Kawagoe, Y., Suzuki, T., Ueda, Y., Yamada, S., Shoji, H., Takeuchi, M., Ueda, S., et al. (2009) · Pharmacological Research
Advanced Glycation End Products researchSepsis Diagnosis and Treatment
Cited by 46
- Verified
Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death
Sakasai-Sakai, A., Takata, T., Takino, J.-I., & Takeuchi, M. (2017) · Scientific Reports
Advanced Glycation End Products researchLiver Disease Diagnosis and Treatment
Cited by 46
- Verified
Short-chain aldehyde-derived ligands for RAGE and their actions on endothelial cells
Yamamoto, Y., Yonekura, H., Watanabe, T., Sakurai, S., Li, H., Harashima, A., Myint, K. M., Osawa, M., Takeuchi, A., Takeuchi, M., et al. (2007) · Diabetes Research and Clinical Practice
Advanced Glycation End Products researchRetinal Diseases and Treatments
Cited by 44
- Verified
Acetaldehyde-Derived Advanced Glycation End-Products Promote Alcoholic Liver Disease
Hayashi, N., George, J., Takeuchi, M., Fukumura, A., Toshikuni, N., Arisawa, T., & Tsutsumi, M. (2013) · PLoS ONE
Alcohol Consumption and Health EffectsAdvanced Glycation End Products research
Cited by 41
- Verified
Neurotoxicity of Acetaldehyde-Derived Advanced Glycation End Products for Cultured Cortical Neurons
Takeuchi, M., Watai, T., Sasaki, N., Choei, H., Iwaki, M., Ashizawa, T., Inagaki, Y., Yamagishi, S.-I., Kikuchi, S., Riederer, P., et al. (2003) · Journal of Neuropathology & Experimental Neurology
Advanced Glycation End Products researchPotato Plant Research
Cited by 36
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free